Peter Buijnsters

机构：Johnson & Johnson (United States) · ORCID：0000-0003-1383-0823

发表论文 31 篇 · 总被引 667 次 · h-index 10

代表论文

• Repurposing High-Throughput Image Assays Enables Biological Activity Prediction for Drug Discovery (2018 · Cell chemical biology · 被引 250)
• Oriented Crystallization of Calcium Carbonate under Self-Organized Monolayers of Amide-Containing Phospholipids (2001 · Langmuir · 被引 73)
• O-GlcNAcase inhibitors as potential therapeutics for the treatment of Alzheimer’s disease and related tauopathies: analysis of the patent literature (2021 · Expert Opinion on Therapeutic Patents · 被引 62)
• Pyrido[4,3- e ][1,2,4]triazolo[4,3- a ]pyrazines as Selective, Brain Penetrant Phosphodiesterase 2 (PDE2) Inhibitors (2015 · ACS Medicinal Chemistry Letters · 被引 56)
• Structure-Based Design of a Potent, Selective, and Brain Penetrating PDE2 Inhibitor with Demonstrated Target Engagement (2014 · ACS Medicinal Chemistry Letters · 被引 51)
• Discovery of a new series of [1,2,4]triazolo[4,3-a]quinoxalines as dual phosphodiesterase 2/phosphodiesterase 10 (PDE2/PDE10) inhibitors (2012 · Bioorganic & Medicinal Chemistry Letters · 被引 29)